Autres langues CanSino Biologics Inc. Shanghai S.E.

Actions

688185

CNE100004BM0

Cours en clôture Shanghai S.E. Autres places de cotation 00:00:00 12/06/2024			Varia. 5j.	Varia. 1 janv.
48,29 ^CNY	-0,45%		-1,00%	-35,20%

10/06	L'Indonésie intensifie la lutte contre la tuberculose en raison des inquiétudes concernant l'impact économique	RE
31/05	CanSino Biologics Inc. annonce la démission de Nisa Bernice Wing-Yu LEUNG en tant qu'administrateur non exécutif et membre du comité de nomination	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Indonesia ramps up fight against tuberculosis amid concerns on economic impact	10/06
CanSino Biologics Inc. Announces Resignation of Nisa Bernice Wing-Yu LEUNG as Non-Executive Director and Member of the Nomination Committee	31/05
Cansino Biologics Invests 160 Million Yuan in China Bohai Bank’s Structured Deposits	21/05
CanSino Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine	29/04
CanSinoBIO CSO Shares Latest Results of the Company's Globally Innovative Pneumococcal Vaccine	26/04
Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine	22/04
CanSino Biologics Inc. Obtains Clinical Trial Approval Granted by the National Medical Products Administration of the People's Republic of China	22/04
Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results	22/04
The Commercialization of Asia's First Meningococcal Conjugate Vaccine From CanSinoBIO Represents a Significant Breakthrough	27/03
CanSino Biologics : CanSinoBIO Initiates Phase Ⅲ Clinical Trial of Group ACYW135 Meningococcal Conjugate Vaccine Menhycia® in Indonesia	25/03
Cansino Biologics Begins Phase III Clinical Trials for Tetanus Drug	21/03
Cansino Biologics Inc. Announces Initiation of Phase III Clinical Trial and Completion of First Trial Patient Case for Absorbed Tetanus Vaccine	20/03
CanSino Biologics Sued by Brazilian Pharma Firm Belcher Over COVID-19 Vaccine Dispute	14/03
Cansino Biologics Inc. Announces Acceptance of Drug Registration Application for 13-Valent Pneumococcal Conjugate Vaccine	28/02
CanSino Biologics' Loss Widens in 2023, Misses EPS, Revenue Estimates; Shares Rise 4%	26/02
Cansino Biologics Inc. Announces Board and Committee Elections	23/02
CanSino Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
CanSino Biologics Deconsolidates CanSino SPH	02/02
CanSino Biologics' Loss to Widen in 2023; Shares Drop 5%	31/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

INTERVIEW - Xuefeng Yu, PDG de CanSino Biologics : Les coulisses de l'accord avec AstraZeneca

Le 31 août 2023 à 12:08